API Maker Hit with Warning Letter for Inadequate Cleaning, Testing Procedures

Drug Industry Daily
A A
The FDA hit CTX Lifesciences with a warning letter for several failures at its India-based drug manufacturing facility and the quality of its active pharmaceutical ingredients.

To View This Article:

Login

Subscribe To Drug Industry Daily